EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Impact of Clinical Characteristics and Treatment on Cholangiocarcinoma Prognosis in Southern Thailand

Chirawadee Sathitruangsak iD, Tanawat Pattarapuntakul, Apichat Kaewdech, Tortrakoon Thongkan, Apinya Prisutkul, Phatcharaporn Thongwatchara, Hutcha Sriplung, Chanon Kongkamol, Kanyanatt Kanokwiroon, Sumalee Obchoei, Pimsiri Sripongpun iD

Cancer Medicine · 2024

DOI: 10.1002/cam4.70491 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2024. Verfasst von Chirawadee Sathitruangsak und 10 weiteren Autor:innen. Beteiligte Einrichtung: Holistic Center for Cancer Study and Care (HOCC-PSU) and Medical Oncology Unit, Division of Internal Medicine, Faculty of Medicine, Prince of Songkla…. Hauptthemen laut MEDLINE: Cholangiocarcinoma, Bile Duct Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Faculty of Medicine, Prince of Songkla University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cholangiocarcinoma (CCA) is most commonly seen in Northeastern Thailand and other parts of Asia where liver flukes are prevalent. However, it is unknown whether CCA patients in low and high liver fluke prevalence areas are similar. This study aimed to analyze the clinical characteristics and outcomes of CCA patients in Southern Thailand.

Methods

We retrospectively reviewed 223 patients diagnosed with CCA between 2018 and 2021 in a tertiary‐care center. Clinicopathologic data were reviewed and compared between intrahepatic, perihilar, and distal CCA (iCCA, pCCA, and dCCA, respectively). Overall survivals (OS) were determined by Kaplan–Meier method and multivariable Cox regressions.

Results

The mean age was 63.9 years; 50.7% were men. The most common subtype was iCCA (49.3%), followed by pCCA (36.3%) and dCCA (14.3%). Most patients were diagnosed at a later stage: 59.4% TMN stage IV and 23.3% stage III. Cirrhosis was present in 6.3%, while the presence of liver fluke was not detected. Only 15.1% of the cohort were deemed resectable. The median OS for iCCA, pCCA, and dCCA patients were 27.3, 22.0, and 19.3 weeks, respectively ( p = 0.9). One‐year survival rate differed significantly between resectable and unresectable patients (85.2% vs. 21.2%, p < 0.0001). TMN stage (aHR 1.88), palliative biliary drainage (aHR 0.31), and systemic chemotherapy (aHR 0.19) were independent predictors for mortality in unresectable pCCA and dCCA patients. In unresectable iCCA patients, only systemic chemotherapy was significant (aHR 0.30).

Conclusion

Most patients were diagnosed late, and the median OS was only 5–6 months. Unresectable CCA patients with systemic chemotherapy and palliative biliary drainage had better survival rates.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CholangiocarcinomaBile Duct NeoplasmsHumansMaleFemaleMiddle AgedThailandRetrospective StudiesAgedPrognosisNeoplasm StagingKaplan-Meier Estimate

Stichwörter der Autor:innen

bile duct cancerhilarintrahepaticperiductalprognosissurvival

Autor:innen und Institutionen

  • Holistic Center for Cancer Study and Care (HOCC-PSU) and Medical Oncology Unit, Division of Internal Medicine, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla, Thailand.
  • Gastroenterology and Hepatology Unit, Division of Internal Medicine, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla, Thailand.
  • Department of Surgery, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla, Thailand.
  • Epidemiology Unit, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla, Thailand.
  • Division of Digital Innovation and Data Analytics, Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand.
  • Department of Biomedical Sciences and Biomedical Engineering, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla, Thailand.

ORCID-Profile: Chirawadee Sathitruangsak, Pimsiri Sripongpun

Förderung

  • Faculty of Medicine, Prince of Songkla University

Zitieren

APA

Sathitruangsak, C., Pattarapuntakul, T., Kaewdech, A., Thongkan, T., Prisutkul, A., Thongwatchara, P., Sriplung, H., Kongkamol, C., Kanokwiroon, K., Obchoei, S., & Sripongpun, P. (2024). Impact of Clinical Characteristics and Treatment on Cholangiocarcinoma Prognosis in Southern Thailand. Cancer Medicine. https://doi.org/10.1002/cam4.70491

Vancouver

Sathitruangsak C, Pattarapuntakul T, Kaewdech A, Thongkan T, Prisutkul A, Thongwatchara P, et al. Impact of Clinical Characteristics and Treatment on Cholangiocarcinoma Prognosis in Southern Thailand. Cancer Medicine. 2024. doi:10.1002/cam4.70491

BibTeX
@article{Sathitruangsak2024,
  author = {Sathitruangsak, Chirawadee and Pattarapuntakul, Tanawat and Kaewdech, Apichat and Thongkan, Tortrakoon and Prisutkul, Apinya and Thongwatchara, Phatcharaporn and Sriplung, Hutcha and Kongkamol, Chanon and Kanokwiroon, Kanyanatt and Obchoei, Sumalee and Sripongpun, Pimsiri},
  title = {Impact of Clinical Characteristics and Treatment on Cholangiocarcinoma Prognosis in Southern Thailand},
  journal = {Cancer Medicine},
  year = {2024},
  doi = {10.1002/cam4.70491}
}
Kostenlos starten →